Home > Products > All > SUCCINYLCHOLINE Chloride Injection, USP*
Product Image
Please see full prescribing and safety information, including boxed warning, for SUCCINYLCHOLINE vials.

Available in:

  • 200 mg per 10 mL multi-dose vials

Benefits:

  • AP Rated
  • Not made with natural rubber latex

Downloads:

PreventIV

SUCCINYLCHOLINE Chloride Injection, USP*

Brand Name Equivalent: QUELICIN® (QUELICIN is a registered trademark of Hospira, Inc.)
Therapeutic Category: Neuromuscular Blocking Agent

PreventIV Measures® Features:

  • Easy-to-read drug name and dosage strength to aid in identifying the right product
  • Bar codes included on the vial and carton for ease of scanning
  • Unique label design to help products stand out on the shelf
  • Enhanced packaging and labeling designed to promote safety and help reduce the risk of medication errors
NDC
#25021		 Description Strength Fill
Volume 		Concentration Container
Size 		Closure Unit
of Sale
677-10 Glass Vial 200 mg 10 mL 20 mg per mL 10 mL 20 mm 25

WARNING: VENTRICULAR DYSRHYTHMIAS, CARDIAC ARREST, AND DEATH FROM HYPERKALEMIC RHABDOMYOLYSIS IN PEDIATRIC PATIENTS

• Acute rhabdomyolysis with hyperkalemia followed by ventricular dysrhythmias, cardiac arrest, and death has occurred after use in apparently healthy pediatric patients who were subsequently found to have undiagnosed skeletal muscle myopathy. (5.1) • When a healthy-appearing pediatric patient develops cardiac arrest soon after administration of succinylcholine, not felt to be due to other causes, immediate treatment for hyperkalemia should be instituted. In the presence of signs of malignant hyperthermia, appropriate treatment should be instituted concurrently. (5.1) • Reserve use of succinylcholine in pediatric patients for emergency intubation or instances where immediate securing of the airway is necessary, or for intramuscular use when a suitable vein is inaccessible. (5.1)